185 related articles for article (PubMed ID: 10470478)
1. Intraprocedural myocardial contrast echocardiography as a routine procedure in percutaneous transluminal septal myocardial ablation: detection of threatening myocardial necrosis distant from the septal target area.
Faber L; Seggewiss H; Ziemssen P; Gleichmann U
Catheter Cardiovasc Interv; 1999 Aug; 47(4):462-6. PubMed ID: 10470478
[TBL] [Abstract][Full Text] [Related]
2. [Myocardial contrast echocardiography guided alcohol septal ablation in hypertrophic obstructive cardiomyopathy with a new echocardiographic contrast agent].
Pfeiffer B; Rigopoulos A; Seggewiß H
Dtsch Med Wochenschr; 2012 Oct; 137(41):2093-6. PubMed ID: 23033167
[TBL] [Abstract][Full Text] [Related]
3. [Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results in 66 patients with reference to myocardial contrast echocardiography].
Faber L; Seggewiss H; Fassbender D; Bogunovic N; Strick S; Schmidt HK; Gleichmann U
Z Kardiol; 1998 Mar; 87(3):191-201. PubMed ID: 9586154
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy.
Seggewiss H; Faber L; Gleichmann U
Thorac Cardiovasc Surg; 1999 Apr; 47(2):94-100. PubMed ID: 10363608
[TBL] [Abstract][Full Text] [Related]
5. Successful percutaneous transluminal septal myocardial ablation through a right superior septal artery for a patient with hypertrophic obstructive cardiomyopathy.
Kurita T; Tsuchikane E; Tanaka N; Suzuki T
Cardiovasc Interv Ther; 2015 Oct; 30(4):377-81. PubMed ID: 25502014
[TBL] [Abstract][Full Text] [Related]
6. Papillary muscles identified by myocardial contrast echocardiography in preparation for percutaneous transluminal septal myocardial ablation.
Harada T; Ohtaki E; Sumiyoshi T
Acta Cardiol; 2002 Feb; 57(1):25-7. PubMed ID: 11918131
[TBL] [Abstract][Full Text] [Related]
7. Targeting percutaneous transluminal septal ablation for hypertrophic obstructive cardiomyopathy by intraprocedural echocardiographic monitoring.
Faber L; Ziemssen P; Seggewiss H
J Am Soc Echocardiogr; 2000 Dec; 13(12):1074-9. PubMed ID: 11119274
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of selective myocardial contrast echocardiography in percutaneous transluminal septal myocardial ablation: a case report.
Okayama H; Sumimoto T; Morioka N; Yamamoto K; Kawada H
Jpn Circ J; 2001 Sep; 65(9):842-4. PubMed ID: 11548888
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.
Tsuchikane E; Takeda Y; Kobayashi T; Yachiku K; Nasu K; Kobayashi Y; Matsumoto H; Awata N
Circ J; 2003 Sep; 67(9):763-7. PubMed ID: 12939552
[TBL] [Abstract][Full Text] [Related]
10. Intracardiac echocardiography guidance during percutaneous transluminal septal myocardial ablation in patients with obstructive hypertrophic cardiomyopathy.
Pedone C; Vijayakumar M; Ligthart JM; Valgimigli M; Biagini E; De Jong N; Serruys PW; Ten Cate FJ
Int J Cardiovasc Intervent; 2005; 7(3):134-7. PubMed ID: 16243734
[TBL] [Abstract][Full Text] [Related]
11. Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy.
Nagueh SF; Lakkis NM; He ZX; Middleton KJ; Killip D; Zoghbi WA; Quiñones MA; Roberts R; Verani MS; Kleiman NS; Spencer WH
J Am Coll Cardiol; 1998 Jul; 32(1):225-9. PubMed ID: 9669274
[TBL] [Abstract][Full Text] [Related]
12. Cardiac electromechanical mapping in analyzing the mechanism of left ventricular remodeling immediately after percutaneous transluminal septal ablation in patients with hypertrophic obstructive cardiomyopathy.
Chen SL; Huang J; Ye F; Shan SJ; Zhang JJ; Duan BX; Chen YD
Chin Med J (Engl); 2005 Nov; 118(21):1779-85. PubMed ID: 16336814
[TBL] [Abstract][Full Text] [Related]
13. [Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy].
Qiao SB; Gao RL; You SJ; Yuan JS; Chen JL; Yang YJ
Zhonghua Nei Ke Za Zhi; 2006 Mar; 45(3):210-2. PubMed ID: 16624154
[TBL] [Abstract][Full Text] [Related]
14. Myocardial perfusion after percutaneous transluminal septal myocardial ablation as assessed by myocardial contrast echocardiography in patients with hypertrophic obstructive cardiomyopathy.
Pedone C; Biagini E; Galema TW; Vletter WB; ten Cate FJ
J Am Soc Echocardiogr; 2006 Aug; 19(8):982-6. PubMed ID: 16880092
[TBL] [Abstract][Full Text] [Related]
15. Echo-guided percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: 7 years of experience.
Faber L; Seggewiss H; Welge D; Fassbender D; Schmidt HK; Gleichmann U; Horstkotte D
Eur J Echocardiogr; 2004 Oct; 5(5):347-55. PubMed ID: 15341870
[TBL] [Abstract][Full Text] [Related]
16. [Percutaneous transluminal septal myocardial ablation: early results and long-term follow-up].
Tekieli Ł; Pieniazek P; Podolec P; Tomkiewicz-Pajak L; Płazak W; Musiałek P; Leśniak-Sobelga A; Przewłocki T; Biernacka B; Zmudka K; Tracz W
Przegl Lek; 2006; 63(8):628-32. PubMed ID: 17441371
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography.
Faber L; Seggewiss H; Gleichmann U
Circulation; 1998 Dec; 98(22):2415-21. PubMed ID: 9832486
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous transluminal septal myocardial ablation in drug-resistant hypertrophic obstructive cardiomyopathy: 18-month follow-up results.
Oomman A; Ramachandran P; Subramanyan K; Kalarickal MS; Osman MN
J Invasive Cardiol; 2001 Jul; 13(7):526-30. PubMed ID: 11435640
[TBL] [Abstract][Full Text] [Related]
19. Unjailing of the septal perforator using a rotational atherectomy device prior to alcohol septal ablation in a patient with symptomatic hypertrophic obstructive cardiomyopathy.
Basir MB; Greenbaum A; O'Neill W
Catheter Cardiovasc Interv; 2014 Sep; 84(3):E26-9. PubMed ID: 24740801
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous transluminal septal myocardial ablation: past, present, and future.
Maekawa Y; Takamisawa I; Takano H; Takayama M
J Cardiol; 2022 Sep; 80(3):211-217. PubMed ID: 34924238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
